PANRETIN is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is Alitretinoin.
| Product ID | 59212-601_1629bcf4-47bc-4203-878f-c7daeb6e8fc7 |
| NDC | 59212-601 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PANRETIN |
| Generic Name | Alitretinoin |
| Dosage Form | Gel |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2019-09-10 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020886 |
| Labeler Name | Concordia Pharmaceuticals Inc. |
| Substance Name | ALITRETINOIN |
| Active Ingredient Strength | 60 mg/60g |
| Pharm Classes | Retinoid [EPC],Retinoids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2019-09-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020886 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-09-10 |
| Ingredient | Strength |
|---|---|
| ALITRETINOIN | 60 mg/60g |
| SPL SET ID: | 49c16717-7d86-4257-80c9-baa1417e5555 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 59212-601 | PANRETIN | alitretinoin |
| 62856-601 | Panretin | Alitretinoin |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PANRETIN 74700355 2149627 Live/Registered |
EISAI INC. 1995-07-12 |